~~<i id='71A29B92E5'><strike id='71A29B92E5'><tt id='71A29B92E5'><pre id='71A29B92E5'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

knowledge

author：entertainment 2025-09-28 01:37:06 - browse：6

On this week’s “Readout LOUD,” we’re live in San Francisco at STAT’s Breakthrough Summit West. AI is a big theme this year, everywhere, so on that note, we chat with our AI correspondent — and recent Pulitzer finalist — Casey Ross, who sat down on stage to discuss AI-centered drug discovery with both NVIDIA and Google-backed Isomorphic Labs.

We also discuss this week’s biotech news, including yet more obesity drug data, this time from Roche, and the closing of Novartis’ acquisition of MorphoSys.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Philips to halt sales of sleep apnea machines in U.S.

focus

entertainment

knowledge

entertainment

focus

leisure time

AdobeWhoamongusislookingforwardtogettingolderin2024?Notsenators(mostofwhomare65andolder),thetwoleadi

WSS

Boston competes with Raleigh

Boston competes with Raleigh

ALS patient reclaims some autonomy thanks to wearable 'robot'

Syphilis numbers in the United States reach record heights

How generative AI ratchets up security threats for health systems

Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

leisure time

knowledge

focus

Cancer drug shortages should be causing more outrage

Vertex non

Guidelines to prevent youth baseball injuries need more muscle

California wildfire smoke linked to 52,000 early deaths, study says

Sports medicine is finally prioritizing gender equality

Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Pharma companies must ensure equitable access to obesity drugs

Alkermes shareholders re

Lilly's Alzheimer's drug donanemab backed by FDA advisers

entertainment

Boston competes with Raleigh

Readout Newsletter: Vertex, Pfizer, Kura, and other biotech news

Report captures long Covid’s disabling effects and policy challenges

How faith leaders like me can help address America's obesity epidemic

ALS patient reclaims some autonomy thanks to wearable 'robot'

How generative AI ratchets up security threats for health systems

knowledge

entertainment

focus

leisure time